BYSI

BeyondSpring Ordinary Shares (BYSI)

About BeyondSpring Ordinary Shares (BYSI)

BeyondSpring, Inc. engages in the development and commercialization of immuno-oncology cancer therapies. It operates through the Plinabulin Pipeline and TPD Platform segments. The Plinabulin Pipeline segment focuses on the development of cancer therapies. The TPD Platform segment engages in the development of therapeutic agents and discover chemical entities. The company was founded by Lan Huang and Lin Qing Jia in 2010 and is headquartered in Florham Park, NJ.

Details

Daily high
$1.60
Daily low
$1.50
Price at open
$1.55
52 Week High
$4.00
52 Week Low
$0.78
Market cap
64.1M
Dividend yield
0.00%
Volume
68,057
Avg. volume
34,594
P/E ratio
-3.99

BeyondSpring Ordinary Shares News

Details

Daily high
$1.60
Daily low
$1.50
Price at open
$1.55
52 Week High
$4.00
52 Week Low
$0.78
Market cap
64.1M
Dividend yield
0.00%
Volume
68,057
Avg. volume
34,594
P/E ratio
-3.99